Roflumilast: What It Is, How It Works, and What You Need to Know

When you’re managing Roflumilast, a once-daily oral medication prescribed for severe chronic obstructive pulmonary disease (COPD) to reduce flare-ups. It’s not a rescue inhaler, and it won’t open your airways right away—but over time, it helps calm the inflammation that makes breathing harder. Roflumilast belongs to a class called phosphodiesterase-4 inhibitors, which target specific enzymes in lung cells to reduce swelling and mucus production. Unlike bronchodilators that relax muscles, this drug works at the root of the problem: ongoing inflammation.

People who take Roflumilast often have a history of frequent COPD exacerbations, even while using other inhalers. It’s usually added to long-acting bronchodilators, not used alone. Think of it like a background check for your lungs—quietly stopping damage before it triggers a flare-up. It’s not for asthma, not for mild COPD, and not for quick relief. But if you’ve had multiple hospital visits due to worsening breathing, this drug might be part of your long-term plan.

Related to Roflumilast are other COPD treatments, a group of medications and therapies designed to manage symptoms and slow progression of chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease includes emphysema and chronic bronchitis, both driven by smoking or long-term exposure to irritants. While inhalers like Advair or Symbicort open airways, and steroids reduce immediate swelling, Roflumilast works deeper—slowing the immune system’s overreaction in the lungs. It’s also connected to phosphodiesterase-4 inhibitors, a class of anti-inflammatory drugs that block enzymes involved in lung inflammation, a small but important group that includes drugs like apremilast, used for psoriasis and arthritis. The same mechanism that helps skin inflammation might help lung tissue too.

Side effects are real—nausea, weight loss, diarrhea, and sometimes mood changes. That’s why it’s not a first-line choice. But for the right person, it can mean fewer emergency visits and more days where breathing feels manageable. It’s not a miracle drug, but it’s a tool that fills a gap many other medications don’t reach.

What you’ll find in the posts below isn’t just about Roflumilast alone. You’ll see how it fits into bigger pictures: how other drugs like bronchodilators or steroids interact with it, how lifestyle changes can boost its effect, and how patients manage the trade-offs between effectiveness and side effects. This isn’t a list of random articles—it’s a collection built around real people trying to hold onto their breathing, one pill, one day at a time.

Fiona Whitley October 25, 2025

Daliresp (Roflumilast) vs Other COPD Treatments: A Side‑by‑Side Comparison

A detailed side‑by‑side comparison of Daliresp (roflumilast) with inhaled steroids, LAMA, LABA/LAMA combos, and other COPD treatments, including benefits, risks, cost and practical guidance.

View More